FINCH THERAPEUTICS GROUP INC (FNCH) Earnings History & Surprises

NASDAQ:FNCH • US31773D2009

Current stock price

1.8 USD
-0.18 (-9.09%)
At close:
1.8001 USD
+0 (+0.01%)
After Hours:

FNCH Earnings overview

Past quarterly earnings results for FINCH THERAPEUTICS GROUP INC (FNCH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A

Last Reported

Most Recent
Release Date
Aug 10, 2023
Period
Q1 / 2024
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2024 - - - -100.00%
Q4 2023 -5.78 - 65.57% - -100.00%
Q3 2023 -5.78 - 77.32% - -100.00%
Q2 2023 -3.24 -4.59 29.41% 77.50% - -100.00%
Q1 2023 -11.40 -2.75 -313.94% - 107K - -69.43%
Q4 2022 -16.80 -10.40 -61.48% -40.00% 10K 408K -97.55% -98.77%
Q3 2022 -25.50 -12.24 -108.33% -12,042.86% 140K 765K -81.70% -98.77%
Q2 2022 -14.40 -12.70 -13.39% -4,400.00% 360K 663K -45.70% -87.28%
Q1 2022 - - 350K - -90.14%
Q4 2021 -12.00 -9.79 -22.55% - 810K 5.1M -84.12% -55.25%
Q3 2021 -0.21 -0.43 50.98% - 11.34M - 540.68%
Q2 2021 -0.32 -0.29 -12.04% - 2.83M - 20.43%
Q1 2021 -1.00 -0.24 -308.50% - 3.55M - 98.32%
Q4 2020 - - 1.81M - -
Q3 2020 - - 1.77M - -
Q2 2020 - - 2.35M - -
Q1 2020 - - 1.79M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

FNCH EPS Q2Q GrowthFNCH EPS Q2Q GrowthEPS Q2Q Growth Q2/22 Q3/22 Q4/22 Q2/23 Q3/23 Q4/23 0 -2K -4K -6K -8K -10K

Revenue Historical Q2Q growth and Acceleration

FNCH Revenue Q2Q GrowthFNCH Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 0 200 400

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

FNCH Overview FNCH Technical Analysis Report FNCH Fundamental Analysis Report FNCH Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

FINCH THERAPEUTICS GROUP INC / FNCH Earnings FAQ

What is the most recent earnings date for FNCH stock?

FINCH THERAPEUTICS GROUP INC (FNCH) last reported earnings on 8/10/2023.

Did FNCH stock beat earnings estimates in the most recent quarter?

FINCH THERAPEUTICS GROUP INC (FNCH) missed EPS estimates and missed revenue estimates in the most recent quarter.